New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss in children of various ages without diabetes are safe and effective. The study is by Dr. Manpreet Kaur Oberoi of the University of Western Ontario in London, Ontario, Canada, and colleagues.
This article was originally published on MedicalXpress.com

